The effect of COX-2 inhibitors on periprosthetic osteolysis
Source abstract
Abstract
We aimed to test the hypothesis that COX(cyclooxygenase)-2 inhibitors suppress periprosthetic osteolysis in a rabbit model. Porous coated titanium bar was inserted into distal femur of 24 skeletally mature New Zealand white rabbits. The rabbits were randomized into 3 groups. Group I (8 rabbits) was the control group. In Group II (8 rabbits), 5mg of ultrahigh molecular weight polyethylene particles was inserted along with prosthesis. In Group III (8 rabbits), the same procedure as in Group II was done and a COX-2 inhibitor (celecoxib, Pharmacia: 10mg/day) was administered for 7 weeks. Rabbits were sacrificed after 8 weeks of implantation. Gross, radiological, histological, and immunohistochemical assessments were done. Gross examination showed that one implant in Group II was loose. In radiological evaluation, focal osteolysis was found in 2 rabbits of Group II and 1 rabbit of Group III. Linear osteolysis was found in 2 rabbits of Group II and 1 rabbit of Group III. On histological examination, focal area of granulation tissue laden with macrophages was observed in 6 rabbits of Group II and 6 rabbits of Group III. The mean number of osteoclasts as demonstrated by tartarate positive acid phosphatase staining was 0.5+/-0.5 in Group I, 6.5+/-2.7 in Group II, 3.6+/-2.6 in Group III (p<0.05). Immunohistochemical staining for inducible nitric acid synthase and COX-2 did not show significant difference between Groups II and III. The overall results of this study suggest that COX-2 inhibitors in the therapeutic dose may have a place in suppressing the process of periprosthetic osteolysis.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Orthopaedic implants and arthroplasty · Bone Tissue Engineering Materials · Total Knee Arthroplasty Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (17)
Show source-provided references
1. Osteolysis
2. The synovial-like membrane at the bone–cement interface in loose total hip replacements and its proposed role in bone lysis10.2106/00004623-198365050-00001 ↗
3. A histological and biochemical comparison of the interface tissues in cementless and cemented hip prosthesis10.1097/00003086-199302000-00023 ↗
4. In vitro and in vivo analysis of membranes from hip prosthesis inserted without cement
5. Press-fit metal-backed alumina sockets10.1097/00003086-200010000-00016 ↗
6. Total hip arthroplasty with use of the Metasul metal-on-metal articulation. Four to seven-year results10.2106/00004623-200006000-00005 ↗
7. Gradient crosslinking of UHMWPE using irradiation in molten state for total joint arthroplasty10.1016/S0142-9612(01)00176-4 ↗
8. Prostaglandin synthase 210.1016/0005-2760(95)00194-8 ↗
9. Current concepts in orthopaedic material and implant fixation10.2106/00004623-199307000-00017 ↗
10. The problems in total hip arthroplasty10.2106/00004623-199306000-00001 ↗
11. Periprosthetic osteolysis in total hip arthroplasty10.2106/00004623-199509000-00022 ↗
12. Nitric oxide and its role in orthopaedic disease
13. Aseptic loosening of total hip replacement10.1302/0301-620X.79B3.0790467 ↗
14. Effect of anti-inflammatory medication on monocyte response to titanium particles10.1002/1097-4636(20001205)52:3<509::AID-JBM9>3.0.CO;2-P ↗
15. Oral penfloxacin inhibits release of tumor necrosis factor-α from human peripheral blood monocytes10.2106/00004623-200107000-00012 ↗
16. Modulation of IL-1b, IL-6, TNF-α and PGE2 by pharmacological agents in explants of membranes from failed total hip replacement10.1053/joca.2002.0846 ↗
17. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis10.1359/jbmr.2001.16.4.660 ↗